116 related articles for article (PubMed ID: 7046584)
1. The biologic significance of amyloid.
Gorevic PD; Cleveland AB; Franklin EC
Ann N Y Acad Sci; 1982; 389():380-94. PubMed ID: 7046584
[No Abstract] [Full Text] [Related]
2. [AL- and AA-amyloidosis (the status of the problem)].
Kochubeĭ LN; Vinogradova OM; Serov VV; Vasil'eva NA; Tomas NIu
Klin Med (Mosk); 1988 Aug; 66(8):7-16. PubMed ID: 3057283
[No Abstract] [Full Text] [Related]
3. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
Westermark GT; Westermark P
FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
[TBL] [Abstract][Full Text] [Related]
4. The cutaneous amyloidoses. Pathogenesis and therapy.
Breathnach SM
Arch Dermatol; 1985 Apr; 121(4):470-5. PubMed ID: 3883907
[No Abstract] [Full Text] [Related]
5. Amyloid A (AA) amyloidosis in CByB6 mice: a model to study gastrointestinal amyloidosis.
Gahane AY; Thakur AK
Amyloid; 2017 Mar; 24(sup1):144-145. PubMed ID: 28434288
[No Abstract] [Full Text] [Related]
6. Targeted treatment for amyloidosis.
Pepys-Vered ME; Pepys MB
Isr Med Assoc J; 2014 May; 16(5):277-80. PubMed ID: 24979830
[No Abstract] [Full Text] [Related]
7. AA amyloidosis and AL amyloidosis.
Isobe T
Intern Med; 1993 Dec; 32(12):919-20. PubMed ID: 8204969
[No Abstract] [Full Text] [Related]
8. Amyloidosis: a familiar problem in the light of current pathogenetic developments.
Kisilevsky R
Lab Invest; 1983 Oct; 49(4):381-90. PubMed ID: 6353059
[No Abstract] [Full Text] [Related]
9. Biology of serum amyloid P component.
Pepys MB; Baltz ML; de Beer FC; Dyck RF; Holford S; Breathnach SM; Black MM; Tribe CR; Evans DJ; Feinstein A
Ann N Y Acad Sci; 1982; 389():286-98. PubMed ID: 7046582
[No Abstract] [Full Text] [Related]
10. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
[TBL] [Abstract][Full Text] [Related]
11. AL amyloidosis: a metabolic disease.
Isobe T
Haematologica; 1989; 74(5):425-9. PubMed ID: 2511110
[No Abstract] [Full Text] [Related]
12. Transmission of systemic AA amyloidosis in animals.
Murakami T; Ishiguro N; Higuchi K
Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
[TBL] [Abstract][Full Text] [Related]
13. Amyloid proteins, precursors, mediator, and enhancer.
Cohen AS; Shirahama T; Sipe JD; Skinner M
Lab Invest; 1983 Jan; 48(1):1-4. PubMed ID: 6401828
[No Abstract] [Full Text] [Related]
14. A simple test for AA amyloid.
Yamada T; Sato J
Amyloid; 2017 Mar; 24(sup1):146. PubMed ID: 28434324
[No Abstract] [Full Text] [Related]
15. Histological study of experimental murine AA amyloidosis.
Kuroiwa M; Aoki K; Izumiyama N
J Electron Microsc (Tokyo); 2003; 52(4):407-13. PubMed ID: 14599103
[TBL] [Abstract][Full Text] [Related]
16. Amyloid P-component and the skin.
Breathnach SM; Hintner H
Clin Dermatol; 1990; 8(2):46-54. PubMed ID: 2224736
[No Abstract] [Full Text] [Related]
17. Senile systemic amyloidosis.
Pitkänen P; Westermark P; Cornwell GG
Am J Pathol; 1984 Dec; 117(3):391-9. PubMed ID: 6507586
[TBL] [Abstract][Full Text] [Related]
18. [Amyloidosis: protein thesaurismosis].
Tena X; Olivé A
Med Clin (Barc); 1994 Sep; 103(9):348-56. PubMed ID: 7967897
[No Abstract] [Full Text] [Related]
19. The changing concepts of amyloid.
Picken MM
Arch Pathol Lab Med; 2001 Jan; 125(1):38-43. PubMed ID: 11151053
[TBL] [Abstract][Full Text] [Related]
20. Amyloid P-component (protein AP) in localized amyloidosis as revealed by an immunocytochemical method.
Westermark P; Shirahama T; Skinner M; Norén P; Cohen AS
Histochemistry; 1981; 71(2):171-5. PubMed ID: 7016817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
